E-M Boneberg

416 total citations
8 papers, 332 citations indexed

About

E-M Boneberg is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, E-M Boneberg has authored 8 papers receiving a total of 332 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Oncology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in E-M Boneberg's work include Angiogenesis and VEGF in Cancer (4 papers), Lymphatic System and Diseases (3 papers) and Cancer, Hypoxia, and Metabolism (2 papers). E-M Boneberg is often cited by papers focused on Angiogenesis and VEGF in Cancer (4 papers), Lymphatic System and Diseases (3 papers) and Cancer, Hypoxia, and Metabolism (2 papers). E-M Boneberg collaborates with scholars based in Switzerland and Germany. E-M Boneberg's co-authors include G. Fürstenberger, Thomas Härtung, Roger von Moos, Jürg Hamacher, Beat Thürlimann, Rudolf Lucas, Ueli Moehrlen, Urs Ziegler, Ernst Reichmann and Martin Meuli and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Surgical Endoscopy.

In The Last Decade

E-M Boneberg

8 papers receiving 325 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E-M Boneberg Switzerland 5 211 155 118 57 54 8 332
Jessica Lam United States 7 203 1.0× 105 0.7× 129 1.1× 42 0.7× 79 1.5× 7 379
Motohiko Tanino Japan 9 151 0.7× 125 0.8× 63 0.5× 31 0.5× 31 0.6× 12 342
Jurriaan Brouwer‐Visser United States 12 239 1.1× 170 1.1× 121 1.0× 46 0.8× 74 1.4× 46 495
Gholamreza Safaee Ardekani Canada 13 302 1.4× 215 1.4× 124 1.1× 81 1.4× 42 0.8× 18 554
Cj Chang Taiwan 4 268 1.3× 68 0.4× 114 1.0× 42 0.7× 21 0.4× 4 342
Julia Sun United States 7 193 0.9× 70 0.5× 74 0.6× 56 1.0× 21 0.4× 8 331
Neşe Güney Türkiye 12 119 0.6× 123 0.8× 59 0.5× 74 1.3× 52 1.0× 20 347
Estelle Daudigeos‐Dubus France 11 161 0.8× 102 0.7× 72 0.6× 89 1.6× 20 0.4× 19 332
Patricia Kuiper Netherlands 8 132 0.6× 129 0.8× 65 0.6× 42 0.7× 67 1.2× 12 430
Saeko Nomura Japan 7 155 0.7× 60 0.4× 135 1.1× 110 1.9× 123 2.3× 9 401

Countries citing papers authored by E-M Boneberg

Since Specialization
Citations

This map shows the geographic impact of E-M Boneberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E-M Boneberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E-M Boneberg more than expected).

Fields of papers citing papers by E-M Boneberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E-M Boneberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E-M Boneberg. The network helps show where E-M Boneberg may publish in the future.

Co-authorship network of co-authors of E-M Boneberg

This figure shows the co-authorship network connecting the top 25 collaborators of E-M Boneberg. A scholar is included among the top collaborators of E-M Boneberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E-M Boneberg. E-M Boneberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Boneberg, E-M, Mathew Simcock, Reinhard Dummer, et al.. (2010). Predictive and prognostic potential of angiogenic serum factors and circulating endothelial cells in metastatic melanoma patients receiving temozolamide plus bevacizumab (SAKK 50/07).. Journal of Clinical Oncology. 28(15_suppl). 8585–8585. 1 indexed citations
2.
Boneberg, E-M, Daniel F. Legler, H Steininger, et al.. (2009). Angiogenesis and lymphangiogenesis are downregulated in primary breast cancer. British Journal of Cancer. 101(4). 605–614. 20 indexed citations
3.
Boneberg, E-M, et al.. (2009). 0011 Angiogenesis and lymphangiogenesis are downregulated in primary breast cancer. The Breast. 18. S21–S21. 1 indexed citations
4.
Moehrlen, Ueli, Urs Ziegler, E-M Boneberg, et al.. (2006). Impact of carbon dioxide versus air pneumoperitoneum on peritoneal cell migration and cell fate. Surgical Endoscopy. 20(10). 1607–1613. 18 indexed citations
5.
Fürstenberger, G., Roger von Moos, Rudolf Lucas, et al.. (2006). Circulating endothelial cells and angiogenic serum factors during neoadjuvant chemotherapy of primary breast cancer. British Journal of Cancer. 94(4). 524–531. 183 indexed citations
6.
Fürstenberger, G., et al.. (2005). Real-time PCR of CD146 mRNA in peripheral blood enables the relative quantification of circulating endothelial cells and is an indicator of angiogenesis. British Journal of Cancer. 93(7). 793–798. 35 indexed citations
7.
Boneberg, E-M, et al.. (2004). Hydrostatic Pressure Induces Apoptosis in the Human Leukaemic T‐Cell Line Jurkat Via the Mitochondrial Pathway. Scandinavian Journal of Immunology. 60(4). 403–411. 1 indexed citations
8.
Boneberg, E-M & Thomas Härtung. (2002). Molecular aspects of anti-inflammatory action of G-CSF. Inflammation Research. 51(3). 119–128. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026